Vitamins A & D inhibit the growth of mycobacteria in radiometric culture

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Greenstein, Robert J ^a   Su, Liya ^a   Brown, Sheldon T ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; COLECALCIFEROL; ISOTRETINOIN; MONENSIN; PHTHALIMIDE; PHYTOMENADIONE; RETINOIC ACID; RETINOL; RETINOL ACETATE; VITAMIN D; VITAMIN K GROUP;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GROWTH INHIBITION; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM PARATUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RADIOMETRIC CULTURE; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; METHODOLOGY; RADIOMETRY;

CORYNEBACTERINEAE; EUKARYOTA; PROKARYOTA;

BETA CAROTENE; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; RADIOMETRY; VITAMIN A; VITAMIN D;

EID: 84855297284     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029631     Document Type: Article

References (46)

1. Mellanby E, Green HN, (1929) Vitamin a as an Anti-Infective Agent: Its Use in the Treatment of Puerperal Septigaemia. Br Med J 1: 984-986.
2. Semba RD, (1999) Vitamin A as "anti-infective" therapy, 1920-1940. J Nutr 129: 783-791.
3. Bruce D, Ooi JH, Yu S, Cantorna MT, (2010) Vitamin D and host resistance to infection? Putting the cart in front of the horse. Exp Biol Med (Maywood) 235: 921-927.
4. Hewison M, (2010) Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol 321: 103-111.
5. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
6. Sutherland R, (1934) Vitamins A and D: Their Relation to Growth and Resistance to Disease. Br Med J 1: 791-795.
7. Ross A, Hämmerling U, (1994) Retinoids and the Immune System. In: Sporn M, Roberts A, Goodman D, editors. The Retinoids: Biology, Chemistry and Medicine. 2 ed New York Raven Press pp. 597-630.
8. Anand PK, Kaul D, Sharma M, (2008) Synergistic action of vitamin D and retinoic acid restricts invasion of macrophages by pathogenic mycobacteria. J Microbiol Immunol Infect 41: 17-25.
9. Flemetakis AC, Tsambaos DG, (1989) Effects of synthetic retinoids on the growth of bacteria and their susceptibility to antibiotics. J Chemother 1: 374-376.
10. Pechere M, Germanier L, Siegenthaler G, Pechere JC, Saurat JH, (2002) The antibacterial activity of topical retinoids: the case of retinaldehyde. Dermatology 205: 153-158.
11. Pattison CL, (1930) Treatment of Bone Tuberculosis by Large Amounts of Vitamins A and D. Br Med J 2: 178-179.
12. Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, et al. (2007) A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 176: 208-213.
13. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, et al. (2011) High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 377: 242-250.
14. Lalor MK, Floyd S, Gorak-Stolinska P, Weir RE, Blitz R, et al. (2011) BCG Vaccination: A Role for Vitamin D? PLoS ONE 6: e16709.
15. Shapira Y, Agmon-Levin N, Shoenfeld Y, (2010) Mycobacterium tuberculosis, autoimmunity, and vitamin D. Clin Rev Allergy Immunol 38: 169-177.
16. Greenstein R, Gillis T, Scollard D, Brown S, (2009) Mycobacteria: Leprosy, a Battle Turned; Tuberculosis, a Battle Raging; Paratuberculosis, a Battle Ignored. In: Fratamico P, Smith J, Brogden K, editors. Sequelae and Long-Term Consequences of Infectious Diseases. First ed Washington DC 20036-2904 ASM Press. American Society for Microbiology pp. 135-168.
17. Greenstein RJ, Su L, Haroutunian V, Shahidi A, Brown ST, (2007) On the Action of Methotrexate and 6-Mercaptopurine on M. avium subspecies paratuberculosis. PLoS ONE 2: e161.
18. Greenstein RJ, Su L, Shahidi A, Brown ST, (2007) On the Action of 5-Amino-Salicylic Acid and Sulfapyridine on M. avium including subspecies paratuberculosis. PLoS ONE 2: e516.
19. Rastogi N, Goh KS, Labrousse V, (1992) Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol. AntimicrobAgents Chemother 36: 2843-2846.
20. Greenstein RJ, Su L, Whitlock R, Brown ST, (2009) Monensin causes dose dependent inhibition of Mycobacterium avium subspecies paratuberculosis in radiometric culture. Gut Pathogens 1: 4.
21. Greenstein RJ, Su L, Brown ST, (2009) On the effect of thalidomide on Mycobacterium avium subspecies paratuberculosis in culture. Int J Infect Dis 13: e254-263.
22. Greenstein RJ, Su L, Juste RA, Brown ST, (2008) On the Action of Cyclosporine A, Rapamycin and Tacrolimus on M. avium including subspecies paratuberculosis. PLoS ONE 3: e2496.
23. Siddiqi SH, Libonati JP, Middlebrook G, (1981) Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 13: 908-912.
24. Rusch-Gerdes S, Pfyffer GE, Casal M, Chadwick M, Siddiqi S, (2006) Multicenter Laboratory Validation of the BACTEC MGIT 960 Technique for Testing Susceptibilities of Mycobacterium tuberculosis to Classical Second-Line Drugs and Newer Antimicrobials. J Clin Microbiol 44: 688-692.
25. Krishnan MY, Manning EJ, Collins MT, (2009) Comparison of three methods for susceptibility testing of Mycobacterium avium subsp. paratuberculosis to 11 antimicrobial drugs. J Antimicrob Chemother 64: 310-316.
26. Damato JJ, Collins MT, (1990) Growth of Mycobacterium paratuberculosis in radiometric, Middlebrook and egg-based media. Vet Microbiol 22: 31-42.
27. Chiodini RJ, Van Kruiningen HJ, Thayer WR, Coutu JA, (1986) Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease. J Clin Microbiol 24: 357-363.
28. Naser SA, Ghobrial G, Romero C, Valentine JF, (2004) Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364: 1039-1044.
29. Bertram MA, Inderlied CB, Yadegar S, Kolanoski P, Yamada JK, et al. (1986) Confirmation of the beige mouse model for study of disseminated infection with Mycobacterium avium complex. J Infect Dis 154: 194-195.
30. Greenstein RJ, Su L, Brown ST, (2010) The Thioamides Methimazole and Thiourea Inhibit Growth of M. avium subspecies paratuberculosis in Culture. PLoS ONE 5: e11099.
31. Greenstein RJ, Su L, Brown SL, (2010) Growth of M. avium subspecies paratuberculosis in Culture Is Enhanced by Nicotinic Acid, Nicotinamide, and α and β Nicotinamide Adenine Dinucleotide. Dig Dis Sci 56: 368-375.
32. Springer B, Lucke K, Calligaris-Maibach R, Ritter C, Bottger EC, (2009) Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation. J Clin Microbiol 47: 1773-1780.
33. Anand PK, Kaul D, (2003) Vitamin D3-dependent pathway regulates TACO gene transcription. Biochem Biophys Res Commun 310: 876-877.
34. Shin SJ, Collins MT, (2008) Thiopurine drugs (azathioprine and 6-mercaptopurine) inhibit Mycobacterium paratuberculosis growth in vitro. Antimicrob Agents Chemother 52: 418-426.
35. Krishnan MY, Manning EJ, Collins MT, (2009) Effects of interactions of antibacterial drugs with each other and with 6-mercaptopurine on in vitro growth of Mycobacterium avium subspecies paratuberculosis. J Antimicrob Chemother 64: 1018-1023.
36. Bernheim F, (1940) The Effect of Salicylate on the Oxygen Uptake of the Tubercle Bacillus. Science 92: 204.
37. Woolley DW, McCarter JR, (1940) Antihemorrhagic compounds as growth factors for the Johne's bacillus. Proc Soc Exp Biol Med 45: 357-360.
38. Bentley R, Meganathan R, (1982) Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiol Rev 46: 241-280.
39. Francis J, Madinaveitia J, Macturk HM, Snow GA, (1949) Isolation from acid-fast bacteria of a growth-factor for Mycobacterium johnei and of a precursor of phthiocol. Nature 163: 365.
40. Francis J, Macturk HM, Madinaveitia J, Snow GA, (1953) Mycobactin, a growth factor for Mycobacterium johnei. I. Isolation from Mycobacterium phlei. Biochem J 55: 596-607.
41. Snow GA, (1970) Mycobactins: iron-chelating growth factors from mycobacteria. Bacteriol Rev 34: 99-125.
42. Kurosu M, Narayanasamy P, Biswas K, Dhiman R, Crick DC, (2007) Discovery of 1,4-dihydroxy-2-naphthoate [corrected] prenyltransferase inhibitors: new drug leads for multidrug-resistant gram-positive pathogens. J Med Chem 50: 3973-3975.
43. Brown ST, Edwards FF, Bernard EM, Tong W, Armstrong D, (1993) Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine. Antimicrob Agents Chemother 37: 398-402.
44. Holick MF, (2011) Vitamin D deficiency in 2010: health benefits of vitamin D and sunlight: a D-bate. Nat Rev Endocrinol 7: 73-75.
45. Nerich V, Jantchou P, Boutron-Ruault MC, Monnet E, Weill A, et al. (2011) Low exposure to sunlight is a risk factor for Crohn's disease. Aliment Pharmacol Ther 33: 940-945.
46. Greenstein RJ, (2003) Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis 3: 507-514.